WEVAX

• All hospital and acute care staff in frontline roles with COVID-19 patients and/or with a high-risk of exposure to COVID-19, including nurses and personal support workers and those performing aerosol-generating procedures:
  • Critical Care Units
  • Emergency Departments and Urgent Care Departments
  • COVID-19 Medical Units
  • Code Blue Teams, rapid response teams
  • General internal medicine and other specialists involved in the direct care of COVID-19 positive patients
• All patient-facing health care workers involved in the COVID-19 response:
  • COVID-19 Specimen Collection Centers (e.g., Assessment centers, community COVID-19 testing locations)
  • Teams supporting outbreak response (e.g., IPAC teams supporting outbreak management, inspectors in the patient environment, redeployed health care workers supporting outbreaks or staffing crisis in congregate living settings)
  • COVID-19 vaccine clinics and mobile immunization teams
  • Mobile Testing Teams
  • COVID-19 Isolation Centers
  • COVID-19 Laboratory Services
  • Current members of Ontario’s Emergency Medical Assistance Team (EMAT) who may be deployed at any time to support an emergency response
• Medical First Responders
  • ORNGE
  • Paramedics
  • Firefighters providing medical first response as part of their regular duties
  • Police and special constables providing medical first response as part of their regular duties
• Community health care workers serving specialized populations including:
  • Needle exchange/syringe programs and supervised consumption and treatment services
  • Indigenous health care service providers including but not limited to:
    • Aboriginal Health Access Centers, Indigenous Community Health Centers,
    • Indigenous Interprofessional Primary Care Teams, and Indigenous Nurse Practitioner-Led Clinics
• Long-term care home and retirement-home health care workers, including nurses and personal support workers and Essential Caregivers
• Individuals working in Community Health Centers serving disproportionally affected communities and/or communities experiencing highest burden of health, social and economic impacts from COVID-19
• Critical health care workers in remote and hard to access communities, e.g., sole practitioner
• Home and community care health care workers, including nurses and personal support workers caring for recipients of chronic homecare and seniors in congregate living facilities or providing hands-on care to COVID-19 patients in the community

• Individuals with malignant disorders and non-hematologic malignant solid tumors that are receiving stable, active treatment (chemotherapy, targeted therapies, immunotherapy), excluding individuals receiving solely hormonal therapy and/or radiation therapy
• Transplant recipients (including solid organ transplants and hematopoietic stem cell transplants)
• Individuals undergoing hemodialysis or peritoneal dialysis
• Individuals who are taking or imminently initiating an anti-CD20 agent (e.g., rituximab, ocrelizumab, ofatumumab)
• Individuals for whom transplant or dialysis initiation is imminent, or whose cancer treatment (excluding solely radiation or hormonal therapy) or anti-CD20 agent therapy, is to be imminently initiated

Patients should discuss the timing of their first and second vaccine dose with their health care provider in order to time the vaccine with any immunosuppressive treatments.

Please contact the Director of Care at the home.

Adults 70+ should receive a second dose at the recommended 28-day dose interval.

You may book an appointment by contacting the booking hotline at 226-773-2200 and indicating that you identify as First Nations, Métis, or Inuit.

This booking service is available from 8 a.m. to 8 p.m. Monday through Friday and 8 a.m. to 4 p.m. Saturday and Sunday.

Due to high call volumes, it may take multiple attempts to speak with a representative.

First Nations, Inuit and Métis perspectives and knowledge sharing on COVID-19 vaccines by Women’s College Hospital, Maad'ookiing Mshkiki – Sharing Medicine